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Background: Intimate Partner Violence (IPV) is a major health issue that involves any physical, sexual or
psychological harm inflicted by a current or former partner. Musculoskeletal injuries represent the second most
prevalent clinical manifestation of IPV. Health care professionals, however, rarely screen women for IPV. Using
qualitative methods, this study aimed to explore the perceived barriers to IPV screening and potential facilitators for
overcoming these barriers among orthopaedic surgeons and surgical trainees.
Methods: We conducted three focus groups with orthopaedic surgeons, senior surgical trainees, and junior surgical
trainees. A semi-structured focus group guide was used to structure the discussions. Transcripts and field notes
from the focus groups were analyzed using the qualitative software program N’Vivo (version 10.0; QSR International,
Melbourne, Australia). To further inform our focus group findings and discuss policy changes, we conducted
interviews with two opinion leaders in the field of orthopaedics. Similar to the focus groups, the interviews were
digitally recorded and transcribed, and then analyzed.
Results: In the analysis, four categories of barriers were identified: surgeon perception barriers; perceived patient
barriers; fracture clinic barriers and orthopaedic health care professional barriers. Some of the facilitators identified
included availability of a crisis team; development of a screening form; presence of IPV posters or buttons in the
fracture clinic; and the need for established policy or government support for IPV screening. The interviewees
identified the need for: the introduction of evidence-based policy aiming to increase awareness about IPV among
health care professionals working within the fracture clinic setting, fostering local and national champions for IPV
screening, and the need to generate change on a local level.
Conclusions: There are a number of perceived barriers to screening women in the fracture clinic for IPV, many of
which can be addressed through increased education and training, and additional resources in the fracture clinic.
Orthopaedic health care professionals are supportive of implementing an IPV screening program in the orthopaedic
fracture clinic.
Keywords: Intimate partner violence (IPV), Musculoskeletal injuries, Barriers, Screening* Correspondence: sprags@mcmaster.ca
1Department of Clinical Epidemiology & Biostatistics, McMaster University,
293 Wellington St. N Suite 110, Hamilton, ON L8L 8E7, Canada
Full list of author information is available at the end of the article
© 2013 Sprague et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Sprague et al. BMC Musculoskeletal Disorders 2013, 14:122 Page 2 of 10
http://www.biomedcentral.com/1471-2474/14/122Background
Intimate Partner Violence (IPV) is described by the
American Medical Association as “a pattern of coercive
behaviors that may include repeated battering and
injury, psychological abuse, sexual assault, progressive
social isolation, deprivation and intimidation” [1]. Injuries
associated with IPV often require treatment provided by
orthopaedic surgeons [2]. Canadian orthopaedic surgeons
may not recognize the extent that IPV affects the patients
seen in their clinics; an overwhelming 87 percent who
participated in a national study believed that female
victims of IPV accounted for less than one percent of
patients in their care [3]. A recent prevalence study found
that one third of women attending two fracture clinics for
an orthopaedic injury had experienced physical, emotional,
and/or sexual abuse within the last 12 months [4]. This
rate of IPV is much greater than the orthopaedic surgeons
estimated [3], and provides a rationale for IPV screening
and support programs in orthopaedic clinics.
To address the low rates of screening, previous studies
have explored barriers to IPV screening among various
health care professionals such as emergency department
health care workers, obstetricians/gynecologists, family
physicians, internists and health care staff in family
planning organizations [5-8]. A recent systematic review
of 22 studies investigating barriers to IPV screening
reported by health care professionals described five
categories of barriers: 1) patient-related barriers; 2) health
care provider fears; 3) lack of resources; 4) personal
barriers; and 5) health care provider misconceptions [8].
Across the included studies, the most commonly cited
barriers to screening for IPV were personal discomfort
with the issue of IPV, lack of time, and lack of knowledge
about IPV [8]. This review did not find any studies that
comprehensively examined the perceived barriers to
IPV screening among health care professionals who
treat patients in the orthopaedic fracture clinic setting [8].
This research aimed to address this gap in the literature
by exploring perceived barriers to IPV screening in
the orthopaedic fracture clinic and by identifying
potential facilitators for addressing these barriers among
orthopaedic surgeons and surgical trainees (senior and
junior orthopaedic residents).
Methods
Qualitative method and rationale
This research was conducted using the qualitative
descriptive approach, a qualitative research method which
aims to provide a descriptive summary of the research
organized in a way that best reflects the data. This
method is described by Sandelowski [9] as being valuable
when straight descriptions are required to provide answers
to questions of special relevance to practitioners and
policy makers.The authors are qualified to conduct this study because
we have an interdisciplinary mix of expertise in qualitative
methods, intimate partner violence, orthopaedic surgery,
and trauma surgery. Some authors had preconceived ideas
of what some of the barriers may be and others did
not. The mixture of areas of expertise contributed to the
multiple perspectives needed to effectively analyze the in-
formation of interest in an appropriate and holistic context.
Data collection
Data were collected through focus groups comprised of
orthopaedic surgeons and orthopaedic surgical trainees.
Focus groups are generally recommended for qualitative
descriptive studies as they typically provide a broad range
of information about experiences [9]. The opportunity for
interactive discussion during the focus groups enhanced
the ability to collect in-depth data on the perceived
barriers to and facilitators for screening for IPV in the
orthopaedic fracture clinic. We conducted three separate
focus groups – one with orthopaedic surgeons, one with
senior surgical trainees, and one with junior surgical
trainees. When transcribing data, we did not record the
names of any participants to preserve their privacy and
confidentiality. We assigned each participant a code, such
as “Surgeon 1” or “Junior resident 2”. The codes were kept
in a secure location and only one member of the team had
access to the codes.
Sampling
Sampling for this study was purposeful with an emphasis
on maximum variation sampling. The goal of purposeful
sampling is to select participants who provide “information-
rich” cases, that is, participants who provide data that
will allow us to learn in-depth about the phenomenon
of interest [10]. In this study, we purposefully sampled to
include variation in health care professional type (i.e.
surgeons and surgical trainees) because we believe that
this variable has the potential to influence experiences with
and perceptions about screening for IPV. The research
coordinator (KM) emailed invitations to the individuals
that were selected to participate until we reached our
intended sample size.
To facilitate an open and comfortable environment for
discussion, the focus groups themselves were homogeneous
in terms of health care professional type. This approach
allowed us to analyze our data within profession type
(i.e. surgeon versus surgical trainee) and to compare our
findings between the two groups. Any common themes
that emerge from variation are particularly relevant to the
research question [10].
Sample size
We included six or seven participants in each focus
group for a total sample size of 20 participants plus two
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[11] in the data to adequately describe the perceptions
about barriers to and facilitators for IPV screening by
orthopaedic surgeons and surgical trainees.
Recruitment
A recent prevalence study conducted at our institution
found that the prevalence of IPV (physical, emotional,
sexual) among female patients in orthopaedic fracture
clinics during a period of 12 months was alarmingly
high; 31.6% [4]. As a result, participants for this research
were recruited from this fracture clinic, as well as two
other fracture clinics in Hamilton, Ontario, all which are
affiliated with an academic teaching institution. Individuals
who agreed to participate in the focus groups were likely
to have an interest in IPV and yield the “information-rich”
cases that are important for qualitative research [10].
Potential participants were sent an email invitation which
briefly outlined the subject, purpose, agenda and expected
outcomes of the focus group. Prior to proceeding with this
study, ethics approval was obtained from the local
Research Ethics Board (Project Number: 11–491). We
asked each participant to sign an informed consent form
before proceeding with the focus group or interview.
Participants were not financially compensated for
participating in this study and they were assured that
their participation or lack thereof would not impact their
employment or residency status.
Focus groups
We used a semi-structured focus group guide to structure
the discussion about health care professionals’ experiences
with and perceptions about screening women for IPV.
This approach is useful as it provides participants with
some guidance on what to discuss while also enabling
exploration of issues that may not have been considered
by the researchers [12]. Participants were also asked to
complete a brief demographic questionnaire.
The focus groups were conducted in private location
at a time convenient for participants and were facilitated
by an experienced focus group facilitator (MS). The
focus groups were digitally recorded and the recordings
were transcribed verbatim.
Structured interviews
To address institutional and personal barriers such as
those identified by the focus group participants, we
recognize that it is important to have institutional support
and changes to policies at a level above the fracture clinic.
We chose to interview two opinion leaders in the field of
orthopaedic surgery, who are well-versed and active in
health policy in the field of orthopaedic surgery. The
purpose of the interviews were to help us to better
understand the barriers at the policy level and to identifyfacilitators for making changes to policy to better
assist IPV victims within the fracture clinic setting. The
independent, semi-structured telephone interviews were
conducted after the completion of the three focus groups
which allowed for a more detailed exploration of the
themes identified during the focus group discussion.
An experienced interviewer (MS) conducted the two
interviews which were digitally recorded and transcribed
verbatim.
Data analysis
In qualitative research, data collection and data analysis
usually occur simultaneously to allow for new themes in
the early data to be incorporated into collection of later
data. In this study, we used field notes from the focus
groups to identify new themes to explore in future focus
groups and we began coding after each focus group. As
data collection proceeded, new data and new insights
about the data were incorporated into the data analysis,
making it reflexive and interactive.
Four investigators (SS, MS, RS, and KM) participated
in the data coding and analysis of the focus groups and
interviews. When all of the transcripts from the focus
groups were coded, the four investigators met to
organize the codes into meaningful clusters [13,14] and
discussed potential relationships between the categories,
a process known as axial coding [15]. The analysis
resulted in an organized and comprehensive summary of
orthopedic surgeons’ and surgical trainees’ experiences
and perceptions related to IPV screening in orthopaedic
fracture clinics. The transcripts from the two interviews
were coded by the four investigators following the
procedures described above.
Transcripts and field notes from the focus groups and
interviews were analyzed using conventional qualitative
content analysis, as recommended for qualitative descrip-
tive studies [9]. In conventional qualitative data analysis
the coding categories are derived directly from the data
rather than using preconceived categories [13,14]. The
qualitative software program N’Vivo (version 10.0; QSR
International, Melbourne, Australia) was used for data
management and analysis.
Rigor
The study’s credibility was ensured by documented evo-
lution of coding and analysis as well as coding decisions
[16]. Rigor was also achieved through the use of multiple
coders, many with a strong knowledge of the IPV
literature, and coding consensus meetings. All categories
were firmly grounded in the data by identifying sections of
the transcripts from which they originated [17] and
quotes were used to illustrate the codes which further
demonstrated a good fit between the data and the
analytic results.
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Participants
We invited ten surgeons, ten junior residents, and ten
senior residents to participate in the focus groups. Each of
our three focus groups included six or seven participants,
with a total of 20 surgeons or surgical trainees par-
ticipating across the three focus groups. The mean age of
the focus group participants was 33.9 ± 8.6 years and the
majority of the focus group participants were male (75%)
(Table 1). The mean length of time in practice for the
orthopaedic surgeons was approximately ten years.
Themes
Four main themes were identified: contextual thoughts
on IPV management, barriers to screening for IPV in
fracture clinics, facilitators for screening for IPV in
fracture clinics, and policy implementation for fracture
clinics. Within the contextual thoughts on IPV, the
following two subthemes were identified: perceptions
and observations, and comparison to external models
in orthopaedics. The focus group discussions yielded
additional subthemes that reflected barriers to screening
for IPV including fracture clinic barriers, perceived
barriers for patients, perceived barriers specific to surgical
trainees, and perceived barriers for surgeons. The
following subthemes under the overall category of
facilitators for IPV screening were identified: system-level
characteristics, fracture clinic processes, and personnel
resources. The policy implementation theme emerged
from the analysis of the two interview transcripts.Table 1 Participant demographics
Item Number (%)
N = 20






South-East Asian 4 (20%)
Asian 2 (10%)




Orthopaedic Surgeon 7 (35%)
Surgical Trainee – Senior Orthopaedic Surgical trainee 6 (30%)
Surgical Trainee – Junior Orthopaedic Surgical trainee 7 (35%)
Length of Time in Practice (Orthopaedic
Surgeons Only) (Mean ± Standard Deviation)
9.4 ± 9.6Contextual thoughts about IPV screening in the fracture
clinic setting
The focus groups began by having participants share
their initial thoughts on IPV and some of their personal
experiences with IPV in the fracture clinic (Figure 1).
One focus group began with the following example, “I
have a face of intimate partner violence and murder. . .
Two patients, one tried to have his wife killed. She
became my patient because they were unsuccessful in
killing her”. Most participants recognized and understood
the importance of screening for IPV in the fracture clinic
setting with one participant noting “I think the screening
is hugely important because it probably opens up a door
to a certain percentage of women that would then open
up and tell you about it” and another describing “I
think we are the first access point for those women”.
The participants also discussed the need for caution when
screening to ensure the safety of the patient.
When discussing perceptions about common presenta-
tions of IPV within the fracture clinic setting one partici-
pated noted, “. . . identification is key. . . that’s the part
that I am most worried about is that I am missing people”;
while another participant described: “. . .the biggest
problem is picking it [intimate partner violence] up ‘cause
I think so much of it is silent”. Another participant
summarized current IPV screening practices: “It seems
like if we are going on our intuition and our sense that
something is wrong, we are doing a bad job with that from
the evidence”.
Surgeons and surgical trainees agreed that they are
more comfortable with screening for and caring for
patients who are victims of child abuse as a result of
policies being in place in fracture clinics and having
received appropriate training. One participant compared
knowing the steps to take after screening for child abuse
with not knowing the steps to take after screening for
IPV: “With children we sort of know what to do, who to
call. There’s like a social work team we call but, you
know, if you screen and then they do sort of come forth
with “yes it was intimate partner violence” I wouldn’t
really know what to do next and so it’s a little
intimidating”.
Participants also discussed selective screening for IPV
(asking people about IPV based on pre-determined risk
factors) versus universal screening for IPV (asking everyone
in the fracture clinic about IPV) within the fracture clinic
setting. For example, one participant said: “I think it’s more
ideal for screening everybody . . . because if not we are
gonna screen people based on our certain assumptions and
I don’t think that’s appropriate”. Most participants recog-
nized the limitations and challenges with selective screen-
ing and agreed that universal screening for IPV in fracture
clinics may be appropriate, citing the success of universal
screening for osteoporosis within the fracture clinic setting.
Figure 1 Contextual thoughts on IPV.
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Participants described how the layout and organization
of many fracture clinics makes it challenging for the
orthopaedic surgeon to have privacy with their patients
(Figure 2). Patients are often accompanied by someone
to their appointments and it is difficult to separate the
patient from this person. In addition, within the
academic setting, orthopaedic surgeons rarely see their
patients alone as they are usually accompanied by surgical
learners when seeing their patients. One participantFigure 2 Perceived barriers for screening for IPV in the fracture clinicexplained: “There’s six other people, at least six plus
learners so probably twelve people listening to every single
conversation I have with patients; it’s not the appropriate
place”. In addition, many fracture clinics follow an open
concept model, with curtains separating exam rooms. One
participant made the following analogy: “The fracture
clinic is the equivalent of a family doctor seeing patients
in their waiting office”.
Focus group participants also identified that adequate
patient histories are not readily available or quickly.
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barrier. Since the patient is often initially seen at the
emergency department or by a surgical trainee, the surgeon
may not be aware of their full history including previous
injuries and the nature of these injuries.
Orthopaedic surgeons and surgical trainees described
that they spend a very limited time with individual
patients and have a high number of patients to see
within their fracture clinic, which makes it difficult to
find the time to appropriately screen for and address
IPV. One participant described: “The biggest thing is
time for orthopaedic surgeons. We see 70 to 80 people
in a five hour clinic so if you do the math that’s less than
a few minutes a person”.
Both the surgeons and surgical trainees identified that
there is a lack of policies on screening for and addressing
IPV within the fracture clinic setting. The following
exchange between the facilitator and several surgeons
exemplifies this concern: Facilitator 1- “So am I right in
understanding that the clinics you work in have no
policies or sort of integrated mechanisms . . . for screening
for intimate partner violence?” Several Surgeons- “None
that I’m aware, that’s correct”.
Perceived barriers for injured patients regarding
screening for IPV
The focus group participants were concerned that
universal screening may be challenging if the patients
are unable to speak, read, and/or write English. They
were also concerned about responding appropriately to
possible cultural differences and distinguishing cultural
practices from signs of IPV.
Another perceived patient barrier identified during the
focus groups was the brief interaction that the patient
has with the surgeon, and that the short amount of time
spent with the patient is focused on the patient’s
orthopaedic problem. As one participant explained, “It’s
hard to develop a feeling of trust in a short period of time”.
The focus group participants acknowledged that IPV
victims may be more comfortable disclosing to females
than males, and the field of orthopaedic surgery is
predominately male.
Focus group participants recognized that a patient-
surgeon power imbalance may be present which could
deter patients from disclosing. One participant described
this imbalance: “There’s already a power balance right
there and then there’s the body language alone and we
almost always wear white coats in there. There’s just a
lot of overlay that would probably inhibit the patient
from disclosing some information”.
There was concern that patients may not want to
disclose IPV, as revealed by the following comment: “If
someone comes into the fracture clinic they may just
want care for their physical injuries”. However, oneparticipant disagreed, stating that “patients tend to
trust medical professionals and may want to open up
to someone”. Participants also discussed that women
may not disclose due to fear of the consequences of
disclosing.Perceived barriers specific to surgical trainees screening
for IPV
In general, the surgical trainee participants felt pre-
occupied with their learning and clinical activities and
felt that they would not have the focus to screen for
IPV. This is demonstrated by the following comment,
“You are trying to do a good job at what you are, you
know, at becoming a good surgeon and that’s taking a
lot of our energy away”.
Surgical trainees have multiple demands on them, as
illustrated by the following quote, “We’re busy with our
. . . patient load and our next exam coming up and our
. . . evaluation and our fellowships and our no jobs and
our everything else that we think about all the time and
. . . that you are going into the OR the next day and you
have to read this tonight. . ..”
The surgical trainees expressed concern about IPV
screening influencing their relationship with the preceptor.
The focus group participants clearly indicated that their
preceptor would have to be supportive and encourage
IPV screening.
The focus group participants also expressed concern
about the lack of education and training that they
received on IPV and consequently they were unsure of
what to do with a positive screen. A few participants felt
fearful about being held accountable due to lack of
ability to identify victims as indicated in the following
comment, “you saw Mrs. Smith . . . she had this injury, it
was obviously domestic violence cause she’s dead now
and this was her fourth occurrence and you didn’t pick
up on it, why not doctor?”.Perceived barriers specific to orthopaedic surgeons
screening for IPV
The participants felt that the orthopaedic culture, which
includes short term interaction with patients and a
certain personality-type, is an important barrier. One
participant explained, “I think it’s a lot of the perceptions
of the surgeon, you know, not that orthopaedics isn’t a
caring profession but there are some people that, you
know, don’t have the best bedside manner. So I can see
people feeling very reluctant to kind of share something
personal”. The orthopaedic surgeons also described the
belief that screening for IPV falls outside of the role of
the orthopaedic surgeon and that they tend to treat the
injury in isolation, as opposed to treating the social and
other medical issues.
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a champion for promoting IPV screening and effective
social support for IPV victims, as described in the
following comment, “There’s no champion right now
who actually works at the fracture clinic”.
System-level characteristics that are facilitators for
screening for IPV in the fracture clinic setting
The participants indicated that trust of the medical
profession was an important facilitator, as patients often
open up to medical professionals (Figure 3). One of the
participants commented, “I’m sometimes surprised at
how open and forthcoming patients are in the short time
you get to know them the things that they’ll tell you. I
mean I think there is a sort of inherent trust in the
medical profession”.
The focus group identified education for surgeons and
surgical trainees as an important facilitator, as described
in the following comment, “I think the next step would
be towards education and make it not just completely
academic but with these things I think you have to have
case scenarios. . .”
Changes to fracture clinic processes that would facilitate
screening for IPV in the fracture clinic
The focus group participants suggested numerous
changes to the fracture clinic environment to facilitate
IPV screening and care for IPV victims. Examples
described included having a private area where surgeons
could talk to patients about confidential issues and
having posters and pamphlets on IPV available within
the fracture clinic to potentially help patients feel more
comfortable with the topic.
Participants noted that having a prepared information
package for surgeons would greatly assist in screening
for IPV. One participant suggested “having something
like a preprinted order pack, an abuse care package soFigure 3 Facilitators for screening for IPV.that I know, not just academically what resources are
available . . . it has resources for the patient that has a
set of orders”.
Another idea that was raised during the focus groups
with having a screening form which the patient would
complete upon presentation to the fracture clinic which
could help to identify high risk patients for the orthopaedic
team to follow-up with.
The focus group participants suggested that they could
flag the charts of potential IPV victims. The following
participant describes this suggestion: “They can stick like
a red dot on the chart or something and then we go okay
maybe that red dot means that we should ask them . . .”
The focus group discussions included suggestions for
changing the infrastructure within the fracture clinic to
facilitate screening for IPV. These suggestions include
ensuring that there is adequate support from all fracture
clinic staff and the hospital.Personnel resources for facilitators for screening for IPV
in the fracture clinic setting
Focus group participants suggested that surgical trainees
have the opportunity to spend more time with patients so
that they can effectively screen for IPV, as suggested in the
following comment: “I think sometimes . . .patients might
actually disclose [IPV] to surgical trainees more than
surgeons because surgical trainees tend to spend more
time with the patient in the fracture clinic in terms of
taking the history and doing the physical exam”.
There was a great deal of discussion on the need for a
dedicated person within the fracture clinic setting to
screen for and manage IPV. The following quote from a
surgical trainee demonstrates this: “When we were doing
the screening for the IPV Prevalence study we had, you
know, students coming in and asking every patient “can
I talk to you in private?” That did it quite effectively”.
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a simple plan in place for the fracture clinic including
the availability of a crisis team. A participant noted,
“You should give them a simple plan that this is a
person to contact when these are the problems in the
fracture clinic or this is the person coming to the clinic
every day three four hours and in case you find some
clue you don’t need to waste much time because you
are busy”.
Policy implementation
Both opinion leaders were asked about the need for local
and national champions to promote the need for IPV
screening and care for victims within the fracture clinic
setting (Figure 4). Both believed that a champion would
be invaluable, as evident from the following quote: “I
think, you always need a champion not only to develop
the policy but also to implement the policy”.
The interviewees identified a need to increase awareness
about IPV among all health care professionals working
within the fracture clinic setting. One opinion leader
explained, “. . .the data that shows in the last year 30% of
women that present to a fracture clinic have been subject
to some type of IPV and I’m not so sure that that people
even know those numbers so I think, you know, getting
the information out there that it impacts a huge segment
of the population, that the impact is substantial . . .”
The interviewees agreed that local policy on IPV
would be beneficial in assisting patients who experience
abuse. As one opinion leader stated, ". . .it’s easier taking
a grassroots approach, you know, go to a smaller entity
like a hospital or clinic. . .if you have enough you know
clinics that a or hospitals that are sort of buying into this
program which is being run more at a grassroots level
then maybe at the sort of provincial or systemic levelFigure 4 Implementation of policies for IPV screening.someone might so oh this is working really well or
seems to be really important, what we need to do is
formalize this".
The need for research to inform policy was also
discussed and both opinion leaders believed that the
implementation of an IPV screening program should be
evidence-based and they supported future research to
better inform the decision makers.Discussion
The present study aimed to identify barriers to and
facilitators for screening and caring for IPV victims in an
orthopaedic fracture clinic setting. The current study
confirmed that many of the barriers to screening for IPV
in other medical specialties are also present within the
fracture clinic setting. In addition, this study identified
several additional barriers and facilitators that are
specific to orthopaedic surgeons, orthopaedic surgery
trainees, and the fracture clinic environment. Briefly,
Sormanti & Smith and Colarossi et al. conducted focus
groups with emergency department surgical trainees and
health care staff at an urban family planning centre to
examine the perceived barriers to screening for IPV in
these specific health care settings. Similar to our findings,
they reported barriers to IPV screening that included time
constraints, unpreparedness to screen for IPV and discuss
the issue comfortably and thoroughly, lack of clarity about
implementation of screening and inadequate referral
resources [5,7]. Waalen et al. conducted a review of
published studies reporting on barriers to IPV screening
among various health care professionals [18]. They found
the following provider-related barriers: a lack of provider
education regarding IPV, lack of time, and lack of effective
interventions. The authors also identified the following
patient-related factors: patient nondisclosure and fear of
offending the patient. This review also reported that
barriers to screening for IPV are documented to be similar
among health care providers across diverse specialties
and medical settings. Waalen et al. did not include any
studies in the field of orthopaedic surgery [18]. A recent
systematic review investigating barriers to IPV screening
reported by a variety of health care professionals found
many barriers that were also identified in the current study
such as a lack of time, language and cultural barriers, lack
of training, and lack of institutional protocols [8]. The
current study identified several barriers that were specific
to orthopaedics that the systematic review did not report
in other specialties. These include lack of a “champion”,
the male-dominated nature of orthopaedics, orthopaedic
culture, and the perception of a patient-surgeon
power imbalance. Interestingly, none of our focus group
participants noted that personal discomfort with IPV, fear
of offending patients, or the perception that abuse is rare
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other specialties [8].
The published literature demonstrates an exploration
of the factors that influence IPV screening in multiple
areas of health care, although none of the previous
literature focuses on orthopaedic fracture clinics. Our
previous research in the field of IPV and orthopaedics
has found that injuries requiring the consultation of an
orthopaedic surgeon account for 28 percent of clinical
manifestations of IPV, but IPV is underemphasized in
this medical specialty [3]. A recent survey of orthopaedic
surgeons reported that nine percent of the respondents
believed that inquiring about IPV was an invasion of the
patient’s privacy, and eleven percent believed that ruling
out IPV as the cause of injury was not part of their duty
[3]. The current study further explored these biases and
identified barriers to screening for and addressing IPV
in the orthopaedic fracture clinic. Many of the barriers
identified in the current study can be addressed with
education and the appropriate resources and infrastructure.
For example, surgeons and trainees can learn how to
approach the topic with sensitivity and confidence in
their knowledge of the appropriate plan to take in the
event that a patient discloses. Additionally, fracture clinics
can be designed or renovated to reflect a more private
environment that is conducive to discussing sensitive
topics such as a patient’s experience with IPV.
Our focus groups found that the participants were, in
general, supportive of implementing practices to improve
IPV screening and care within the orthopaedic fracture
clinic setting. They identified numerous facilitators,
which could be implemented into orthopaedic fracture
clinics to help effectively identify and help IPV victims.
After analyzing our codes from the three focus group
transcripts, it was apparent that there were many shared
opinions, attitudes, and experiences among participants.
For example, a common theme identified in each focus
group discussion was a lack of time and privacy. However,
some of the barriers identified by the surgical trainees
were unique because they did not apply to the practicing
orthopaedic surgeons (e.g. surgical trainee preceptor
relationship). There were no other differences in the
responses between groups. Our interviews with opinion
leaders confirmed the findings from the focus groups and
provided insight into and suggestions for implementing
policies for IPV screening and providing health care
professionals with the structure and support to effectively
care for IPV victims.
Our methodology aimed to reduce bias and yield a
purposeful sample. The qualitative descriptive method
chosen for this research minimizes researcher biases as
this method involves minimal interpretation of data and
focuses on presenting and organizing the data in the
language used by participants [19]. Recruiting volunteersto participate likely led to a bias of having individuals who
are interested in the topic of IPV screening participate in
our research. Since the goal in purposeful sampling is to
include participants who can provide “information-rich”
data [10], this bias is favorable as participants who have an
interest in IPV screening are likely able to provide detailed
information, experiences and perceptions about perceived
barriers to and facilitators for IPV screening. In addition,
the questions within the focus group guide were worded
to ensure that they were neutral and did not lead the
participants. The focus group facilitator used neutral
probes and reflective statements to clarify what had
already been discussed and to encourage more discussion
among participants. The use of homogenous groups of
professionals ensured that participants within each focus
group had similar education levels and clinical expertise
which helped to minimize bias related to conforming and
suppressing minority views that might be different from
views of dominant participants within the group.
This study is limited by a relatively small sample size
and by having all focus group participants affiliated with
one academic institution. We are also limited by having
only interviewed two opinion leaders and therefore, the
results of these interviews should be interpreted cautiously.
The two opinion leaders were from different academic
institutions which may improve the generalizability of our
findings, and it should be noted that there are few opinion
leaders in the field of orthopaedics in Canada who are
well-versed on the topic of IPV and health policy. It is
important to note that there may have been bias in
deriving our focus group sample exclusively from one
academic institution because this community of health
care professionals and trainees has had previous exposure
to IPV through education initiatives to increase awareness
and sensitivity to the issue. Additionally, researchers at
this institution have published research focusing on IPV
within the field of orthopaedic surgery. This unique
culture may have influenced the attitudes and opinions of
the orthopaedic surgeons and surgical trainees and this
may limit the external validity of our results. This
study warrants replication in other jurisdictions and in a
community setting to further determine the generalizability
of the findings. Future research could also investigate
patients’ opinions of screening and caring for IPV victims
within the orthopaedic fracture clinic setting.
Conclusions
There are a number of perceived barriers to screening
women in the fracture clinic for IPV, many of which
can be addressed through increased education and
training, and additional resources in the fracture clinic.
Orthopaedic health care professionals are supportive of
implementing an IPV screening program in the ortho-
paedic fracture clinic.
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